Kaken Pharmaceutical
TSE:4521
¥ 4.285,00
+ ¥20,00 (0,47%)
4.285,00 ¥
+¥20,00 (0,47%)
End-of-day quote: 03/06/2026

Quick Analysis

The quick analysis data is updated as follows:

  • G (Growth Rate): Every 3 months when the company releases quarterly figures.
  • R (Risk Analysis): Every 12 months when the company publishes its annual financial statements.
  • O (Outlook): At the daily closing price.
  • W (Margin of safety): At the daily closing price.
  • T (Analyst Price Target): At the daily closing price.
  • H (Trend): At the weekly closing price.

A word about the trend:

The trend is not updated daily, as the GROWTH strategy is based on weekly prices. If necessary, you can check the valuation chart to see if the price has broken the daily trend.

G
0%
3-year Growth Rate
R
0/0
3-year Risk Analysis
O
-57,57%
Outlook 03/26
W
-144%
Margin of safety
T
-1,98%
Analyst Price Target
H
UP
50-week EMA Trend

Company Info

EPS Growth 5Y
-5,89%
Revenue growth 5Y
0,00%
Price growth 5Y
21,01%
Market Cap
¥161,51 B
Long-Term Debt
¥0,00 B
Annual earnings
05/09/2026 (E)
Dividend
¥190,68
Dividend Yield
4,45%
Industry
Country
ISIN Number

Kaken Pharmaceutical Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target

¥4.200,00
-1.98%
-1.98
Last Update: 03/05/2026
Analysts: 3

Highest Price Target ¥5.400,00

Average Price Target ¥4.200,00

Lowest Price Target ¥3.600,00

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
Kaken Pharmaceutical
TSE:4521
23,69% 21,01% 2,68% 0,00% 0/0 -57,57% -144,32% -1,52% UP
×